LIMINAL BIOSCIENCES INC
COM · CUSIP 53272L103
15
institutional holders
3.4m
shares reported held*
$28.1mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.38.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| Consonance Capital Management LP 1.68% of their portfolio | 3.3m $27.5m | — |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 41.4k $335.9k | — |
| MORGAN STANLEY 0.00% of their portfolio | 16.8k $140.0k | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 8.5k $71.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 2.2k $18.0k | — |
| UBS Group AG 0.00% of their portfolio | 1.2k $10.0k | — |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 600 $5.0k | — |
| BANK OF MONTREAL /CAN/ 0.00% of their portfolio | 439 $4.0k | — |
| RBC Europe Ltd 0.00% of their portfolio | 234 $2.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 111 $1.0k | — |
| TORONTO DOMINION BANK 0.00% of their portfolio | 45 $0 | — |
| TANAKA CAPITAL MANAGEMENT INC 0.00% of their portfolio | 22 $0 | — |
| CITIGROUP INC 0.00% of their portfolio | 1 $0 | — |
| Advisor Group, Inc. 0.00% of their portfolio | 1 $0 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |